U.S. FDA Warns About Schering AG And Genzyme Corporation Drug In MS Trial

WASHINGTON, Nov 30 (Reuters) - The U.S. Food and Drug Administration issued a health alert on Wednesday over the use of Genzyme Corp. and Schering AG's drug Campath in a clinical trial to treat multiple sclerosis.